The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| 2Seventy Bio Inc | COMMON STOCK | 901384107 | 6,070 | 459,836 | SH | OTR | 459,836 | 0 | 0 | ||
| 89Bio Inc | COM | 282559103 | 4,508 | 1,400,000 | SH | OTR | 1,400,000 | 0 | 0 | ||
| Acadia Pharmaceuticals Inc | COM | 004225108 | 17,809 | 1,263,930 | SH | OTR | 1,263,930 | 0 | 0 | ||
| Akero Therapeutics Inc | COM | 00973Y108 | 7,858 | 831,495 | SH | OTR | 831,495 | 0 | 0 | ||
| Aligos Therapeutics Inc | COM | 01626L105 | 1,847 | 1,526,048 | SH | OTR | 1,526,048 | 0 | 0 | ||
| Amicus Therapeutics Inc | COM | 03152W109 | 24,971 | 2,325,000 | SH | OTR | 2,325,000 | 0 | 0 | ||
| Amylyx Pharmaceuticals Inc | COM | 03237H101 | 42,372 | 2,200,000 | SH | OTR | 2,200,000 | 0 | 0 | ||
| AnaptysBio Inc | COM | 032724106 | 26,390 | 1,300,000 | SH | OTR | 1,300,000 | 0 | 0 | ||
| Apellis Pharmaceuticals Inc | COM | 03753U106 | 58,953 | 1,303,700 | SH | OTR | 1,303,700 | 0 | 0 | ||
| Arcus Biosciences Inc | COM | 03969F109 | 36,292 | 1,432,200 | SH | OTR | 1,432,200 | 0 | 0 | ||
| Ascendis Pharma A/S | SPONSORED ADR | 04351P101 | 6,507 | 70,000 | SH | OTR | 70,000 | 0 | 0 | ||
| Atreca Inc | CL A COM | 04965G109 | 3,942 | 2,202,333 | SH | OTR | 2,202,333 | 0 | 0 | ||
| Avidity Biosciences Inc | COM | 05370A108 | 16,293 | 1,121,327 | SH | OTR | 1,121,327 | 0 | 0 | ||
| BeiGene Ltd | SPONSORED ADR | 07725L102 | 80,925 | 500,000 | SH | OTR | 500,000 | 0 | 0 | ||
| Bellicum Pharmaceuticals Inc | COM NEW | 079481404 | 68 | 56,950 | SH | OTR | 56,950 | 0 | 0 | ||
| Bellus Health Inc New | COM NEW | 07987C204 | 29,568 | 3,200,000 | SH | OTR | 3,200,000 | 0 | 0 | ||
| BioAtla Inc | COM | 09077B104 | 1,956 | 686,347 | SH | OTR | 686,347 | 0 | 0 | ||
| Biomea Fusion Inc | COM | 09077A106 | 14,237 | 1,188,405 | SH | OTR | 1,188,405 | 0 | 0 | ||
| Black Diamond Therapeutics I | COM | 09203E105 | 4,957 | 2,014,858 | SH | OTR | 2,014,858 | 0 | 0 | ||
| BCLS Acquisition Corp | COM CL A | G0904B105 | 4,950 | 500,000 | SH | OTR | 500,000 | 0 | 0 | ||
| Blueprint Medicines Corp | COM | 09627Y109 | 25,627 | 507,374 | SH | OTR | 507,374 | 0 | 0 | ||
| Cabaletta Bio Inc | COM | 12674W109 | 572 | 540,000 | SH | OTR | 540,000 | 0 | 0 | ||
| Centessa Pharmaceuticals PLC | SPONSORED ADS | 152309100 | 6,093 | 1,251,137 | SH | OTR | 1,251,137 | 0 | 0 | ||
| Codiak Biosciences Inc | COM | 192010106 | 2,448 | 850,065 | SH | OTR | 850,065 | 0 | 0 | ||
| Cogent Biosciences Inc | COM | 19240Q201 | 3,834 | 425,000 | SH | OTR | 425,000 | 0 | 0 | ||
| Cullinan Oncology Inc | COM | 230031106 | 13,770 | 1,074,082 | SH | OTR | 1,074,082 | 0 | 0 | ||
| Cytokinetics Inc | COM NEW | 23282W605 | 82,509 | 2,100,000 | SH | OTR | 2,100,000 | 0 | 0 | ||
| Day One Biopharmaceuticals | COM | 23954D109 | 21,300 | 1,189,943 | SH | OTR | 1,189,943 | 0 | 0 | ||
| DBV Technologies S A | SPONSORED ADR | 23306J101 | 5,443 | 2,134,598 | SH | OTR | 2,134,598 | 0 | 0 | ||
| Elevation Oncology Inc | COM | 28623U101 | 1,222 | 872,780 | SH | OTR | 872,780 | 0 | 0 | ||
| EQRx Inc | COM | 26886C107 | 4,690 | 1,000,000 | SH | OTR | 1,000,000 | 0 | 0 | ||
| Essa Pharma Inc | COM NEW | 29668H708 | 2,282 | 724,500 | SH | OTR | 724,500 | 0 | 0 | ||
| Fate Therapeutics Inc | COM | 31189P102 | 12,390 | 500,000 | SH | OTR | 500,000 | 0 | 0 | ||
| Gemini Therapeutics Inc | COM | 36870G105 | 2,197 | 1,300,000 | SH | OTR | 1,300,000 | 0 | 0 | ||
| GH Research PLC | ORDINARY SHARES | G3855L106 | 10,114 | 1,013,399 | SH | OTR | 1,013,399 | 0 | 0 | ||
| Gossamer Bio Inc | COM | 38341P102 | 20,610 | 2,462,358 | SH | OTR | 2,462,358 | 0 | 0 | ||
| Health Sciences Acq Corp 2 | ORD SHS | G4411D109 | 3,984 | 400,000 | SH | OTR | 400,000 | 0 | 0 | ||
| Ideaya Biosciences Inc | COM | 45166A102 | 30,399 | 2,202,812 | SH | OTR | 2,202,812 | 0 | 0 | ||
| Iovance Biotherapeutics Inc | COM | 462260100 | 21,364 | 1,935,133 | SH | OTR | 1,935,133 | 0 | 0 | ||
| iTeos Therapeutics Inc | COM | 46565G104 | 44,374 | 2,154,058 | SH | OTR | 2,154,058 | 0 | 0 | ||
| Kinnate Biopharma Inc | COM | 49705R105 | 23,298 | 1,847,559 | SH | OTR | 1,847,559 | 0 | 0 | ||
| MEI Pharma Inc | COM NEW | 55279B202 | 1,762 | 2,913,091 | SH | OTR | 2,913,091 | 0 | 0 | ||
| Mereo Biopharma Group PLC | ADS | 589492107 | 2,520 | 2,250,000 | SH | OTR | 2,250,000 | 0 | 0 | ||
| Merus N V | COM | N5749R100 | 43,016 | 1,900,000 | SH | OTR | 1,900,000 | 0 | 0 | ||
| Milestone Pharmaceuticals In | COM | 59935V107 | 13,769 | 2,238,861 | SH | OTR | 2,238,861 | 0 | 0 | ||
| Mirati Therapeutics Inc | COM | 60468T105 | 134,260 | 2,000,000 | SH | OTR | 2,000,000 | 0 | 0 | ||
| NGM Biopharmaceuticals Inc | COM | 62921N105 | 6,410 | 500,000 | SH | OTR | 500,000 | 0 | 0 | ||
| Nurix Therapeutics Inc | COM | 67080M103 | 15,519 | 1,224,892 | SH | OTR | 1,224,892 | 0 | 0 | ||
| Nuvalent Inc | COM | 670703107 | 16,410 | 1,210,192 | SH | OTR | 1,210,192 | 0 | 0 | ||
| Nuvation Bio Inc | COM CL A | 67080N101 | 14,065 | 4,341,009 | SH | OTR | 4,341,009 | 0 | 0 | ||
| Nuvation Bio Inc | *W EXP 07/07/202 | 67080N119 | 75 | 266,666 | SH | OTR | 266,666 | 0 | 0 | ||
| Omega Alpha SPAC | CL A | G6749V107 | 1,970 | 200,000 | SH | OTR | 200,000 | 0 | 0 | ||
| Oric Pharmaceuticals Inc | COM | 68622P109 | 4,722 | 1,054,000 | SH | OTR | 1,054,000 | 0 | 0 | ||
| Panacea Acquisition Corp II | CL A SHS | G6882C106 | 4,880 | 500,000 | SH | OTR | 500,000 | 0 | 0 | ||
| PMV Pharmaceuticals Inc | COM | 69353Y103 | 49,856 | 3,498,636 | SH | OTR | 3,498,636 | 0 | 0 | ||
| Point Biopharma Global Inc | COM | 730541109 | 17,025 | 2,500,000 | SH | OTR | 2,500,000 | 0 | 0 | ||
| Prometheus Biosciences Inc | COM | 74349U108 | 48,386 | 1,714,000 | SH | OTR | 1,714,000 | 0 | 0 | ||
| Protara Therapeutics Inc | COM STK | 74365U107 | 613 | 209,227 | SH | OTR | 209,227 | 0 | 0 | ||
| Prothena Corp PLC | SHS | G72800108 | 8,145 | 300,000 | SH | OTR | 300,000 | 0 | 0 | ||
| Rain Therapeutics Inc | COM | 75082Q105 | 6,533 | 1,175,000 | SH | OTR | 1,175,000 | 0 | 0 | ||
| Reata Pharmaceuticals Inc | CL A | 75615P103 | 37,653 | 1,239,000 | SH | OTR | 1,239,000 | 0 | 0 | ||
| Relay Therapeutics Inc | COM | 75943R102 | 44,708 | 2,669,132 | SH | OTR | 2,669,132 | 0 | 0 | ||
| Revolution Medicines Inc | COM | 76155X100 | 67,908 | 3,484,264 | SH | OTR | 3,484,264 | 0 | 0 | ||
| Rocket Pharmaceuticals Inc | COM | 77313F106 | 20,173 | 1,466,051 | SH | OTR | 1,466,051 | 0 | 0 | ||
| Sage Therapeutics Inc | COM | 78667J108 | 35,336 | 1,094,000 | SH | OTR | 1,094,000 | 0 | 0 | ||
| Sarepta Therapeutics Inc | COM | 803607100 | 14,992 | 200,000 | SH | OTR | 200,000 | 0 | 0 | ||
| Selecta Biosciences Inc | COM | 816212104 | 4,302 | 3,284,072 | SH | OTR | 3,284,072 | 0 | 0 | ||
| Solid Biosciences Inc | COM | 83422E105 | 3,285 | 5,336,031 | SH | OTR | 5,336,031 | 0 | 0 | ||
| Springworks Therapeutics Inc | COM | 85205L107 | 51,109 | 2,075,905 | SH | OTR | 2,075,905 | 0 | 0 | ||
| Surrozen Inc | W EXP 08/01/203 | 86889P117 | 13 | 66,666 | SH | OTR | 66,666 | 0 | 0 | ||
| Tango Therapeutics Inc | COM | 87583X109 | 31,129 | 6,871,642 | SH | OTR | 6,871,642 | 0 | 0 | ||
| Theseus Pharmaceuticals Inc | COM | 88369M101 | 4,933 | 892,057 | SH | OTR | 892,057 | 0 | 0 | ||
| Turning Point Therapeutics I | COM | 90041T108 | 42,949 | 570,745 | SH | OTR | 570,745 | 0 | 0 | ||
| Tyra Biosciences Inc | COM | 90240B106 | 46,106 | 6,448,359 | SH | OTR | 6,448,359 | 0 | 0 | ||
| SPDR SER TR | S&P BIOTECH | 78464A870 | 37,135 | 500,000 | SH | OTR | 500,000 | 0 | 0 | ||
| Xenon Pharmaceuticals Inc | COM | 98420N105 | 18,252 | 600,000 | SH | OTR | 600,000 | 0 | 0 | ||